Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial

The Lancet

Volumn 387, Issue 10016, 2016, Pages 357-366

  Sabaté, Manel ^a   Brugaletta, Salvatore ^a   Cequier, Angel ^b   Iñiguez, Andrés ^c   Serra, Antonio ^d   Jiménez Quevedo, Pilar ^e   Mainar, Vicente ^f   Campo, Gianluca ^g   Tespili, Maurizio ^h   Den Heijer, Peter ⁱ   Bethencourt, Armando ^j   Vazquez, Nicolás ^k   Van Es, Gerrit Anne ^l   Backx, Bianca ^l   Valgimigli, Marco ^m,n   Serruys, Patrick W ^o  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DO MEIXOEIRO   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^g UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^h University Hospital Bolognini Seriate   (Italy)

ⁱ AMPHIA HOSPITAL   (Netherlands)

^j HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^k HOSPITAL JUAN CANALEJO   (Spain)

^l CARDIALYSIS   (Netherlands)

^m ERASMUS MEDICAL CENTER   (Netherlands)

ⁿ UNIVERSITY OF BERN   (Switzerland)

^o IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARE METAL STENT; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CONTROLLED STUDY; DEVICE COMPARISON; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INFECTION; INTENTION TO TREAT ANALYSIS; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEOPLASM; NETHERLANDS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SINGLE BLIND PROCEDURE; SPAIN; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; AGED; BIOASSAY; CLINICAL TRIAL; DRUG ELUTING STENT; EUROPE; KAPLAN MEIER METHOD; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; STATISTICS AND NUMERICAL DATA; STENT; THROMBOSIS;

EVEROLIMUS; METAL;

AGED; CAUSE OF DEATH; DRUG-ELUTING STENTS; ENDPOINT DETERMINATION; EUROPE; EVEROLIMUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METALS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PATIENT OUTCOME ASSESSMENT; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; STENTS; THROMBOSIS;

EID: 84959537539     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00548-6     Document Type: Article

References (36)

1. S Windecker, P Kolh, F Alfonso et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 35 2014 2541 2619
2. PG Steg, KA Fox, KA Eagle et al. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events Eur Heart J 30 2009 321 329
3. C Spaulding, P Henry, E Teiger et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction N Engl J Med 355 2006 1093 1104
4. M Valgimigli, G Campo, C Arcozzi et al. Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study J Am Coll Cardiol 50 2007 138 145
5. GW Stone, B Witzenbichler, G Guagliumi on behalf of the HORIZONS-AMI Trial Investigators Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Lancet 377 2011 2193 2204
6. A Kastrati, A Dibra, C Spaulding et al. Meta-analysis of randomised trials on drug-eluting stents vs bare-metal stents in patients with acute myocardial infarction Eur Heart J 28 2007 270613
7. C Stettler, S Wandel, S Allemann et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948
8. P Wenaweser, J Daemen, M Zwahlen et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
9. A Kastrati, J Mehilli, J Pache et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039
10. GW Stone, JW Moses, SG Ellis et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
11. G Nakazawa, AV Finn, M Joner et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study Circulation 118 2008 1138 1145
12. AV Finn, G Nakazawa, M Joner et al. Vascular responses to drug eluting stents: importance of delayed healing Arterioscler Thromb Vasc Biol 27 2007 1500 1510
13. S Cook, E Ladich, G Nakazawa et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis Circulation 120 2009 391 399
14. M Joner, AV Finn, A Farb et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
15. GJ Wilson, G Nakazawa, RS Schwartz et al. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries Circulation 120 2009 141 149
16. SJ Park, SJ Kang, R Virmani, M Nakano, Y Ueda In-stent neoatherosclerosis: a final common pathway of late stent failure J Am Coll Cardiol 59 2012 2051 2057
17. T Yonetsu, JS Kim, K Kato et al. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography Am J Cardiol 110 2012 933 939
18. M Valgimigli, M Sabaté, C Kaiser et al. Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis BMJ 349 2014 g6427
19. U Baber, R Mehran, SK Sharma et al. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials J Am Coll Cardiol 58 2011 1569 1577
20. M Sabaté, A Cequier, A Iniguez et al. Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction EuroIntervention 7 2011 977 984
21. M Sabaté, A Cequier, A Iñiguez et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 380 2012 1482 1490
22. M Sabaté, S Brugaletta, A Cequier et al. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomised controlled trial JACC Cardiovasc Interv 7 2014 64 71
23. DE Cutlip, S Windecker, R Mehran et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
24. P Vranckx, DE Cutlip, R Mehran et al. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies EuroIntervention 5 2010 871 874
25. PW Serruys, P Ruygrok, J Neuzner et al. A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial EuroIntervention 2 2006 286 294
26. K Kolandaivelu, R Swaminathan, WJ Gibson et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings Circulation 123 2011 1400 1409
27. N Gonzalo, P Barlis, PW Serruys et al. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography JACC Cardiovasc Interv 2 2009 445 452
28. S Puricel, D Arroyo, N Corpataux et al. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds J Am Coll Cardiol 65 2015 791 801
29. J Gomez-Lara, S Brugaletta, V Farooq et al. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography JACC Cardiovasc Interv 4 2011 1271 1280
30. N Tada, R Virmani, G Grant et al. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model Circ Cardiovasc Interv 3 2010 174 183
31. G Nakazawa, T Shinke, T Ijichi et al. Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model EuroIntervention 10 2014 717 723
32. M Takano, D Murakami, M Yamamoto et al. Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents Int J Cardiol 166 2013 181 186
33. T Mizoguchi, T Sawada, T Shinke et al. Detailed comparison of intra-stent conditions 12 months after implantation of everolimus-eluting stents in patients with ST-segment elevation myocardial infarction or stable angina pectoris Int J Cardiol 171 2014 224 230
34. T Palmerini, G Biondi-Zoccai, D Della Riva et al. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis J Am Coll Cardiol 62 2013 496 504
35. SH Hofma, J Brouwer, MA Velders et al. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomised XAMI (XienceV stent vs. Cypher stent in primary PCI for Acute Myocardial Infarction) trial J Am Coll Cardiol 60 2012 381 387
36. MP Bonaca, DL Bhatt, M Cohen PEGASUS-TIMI 54 Steering Committee and Investigators Long-term use of ticagrelor in patients with prior myocardial infarction N Engl J Med 372 2015 1791 1800